Microdose cancer drug test could reveal best treatments without side effects

NCT ID NCT04541108

Ongoing Knowledge-focused Sponsor: Presage Biosciences Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-phase study tests very small amounts of cancer drugs injected directly into accessible tumors in 15 adults scheduled for surgery. The goal is to see how the drugs affect the tumor's environment, like killing cancer cells or activating immune cells, without causing full-body side effects. It is a research tool to gather information, not a treatment itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Head and Neck Neoplasms lymphoma melanoma neoplasm sarcoma Squamous Cell Carcinoma of Head and Neck

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SOLID TUMOR

Contacts and locations

Locations

LSU Health Sciences Center - Shreveport

Shreveport, Louisiana, 71115, United States
MUSC Hollings Cancer Center

Charleston, South Carolina, 29425, United States
Montefiore Medical Center

The Bronx, New York, 10467, United States
Oregon Health & Science University (OHSU)

Portland, Oregon, 97239, United States
Sarah Cannon Research Institute

Charleston, South Carolina, 29406, United States
UC Health

Cincinnati, Ohio, 45229, United States
University of North Carolina

Chapel Hill, North Carolina, 27599, United States
University of Pennsylvania

Philadelphia, Pennsylvania, 19107, United States
University of Washington

Seattle, Washington, 98109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.